Physicians Own Less Than Half of US Practices; Federal Agencies Want Outside InputApril 17, 2024Business of Medicine
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024DLBCLPatient & Survivor CarePediatricsMixed TopicsALLAggressive LymphomasB Cell Lymphoma
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024DLBCLMixed TopicsPatient & Survivor CareAggressive LymphomasALLAMLB Cell Lymphoma
Abecma Approved for Earlier Lines in Relapsed/Refractory Multiple MyelomaApril 9, 2024Multiple MyelomaCellular Therapy
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024Patient & Survivor CareDLBCLPediatricsALLAggressive LymphomasAMLB Cell Lymphoma
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Patient & Survivor CareOpioid Resource CenterFast Facts FridayDLBCLMixed TopicsAggressive LymphomasALL
Blood Cancer Emergencies: Hematologists’ Late-Night CallsApril 3, 2024Mixed TopicsAMLCLLALLNon-Hodgkin LymphomaCML
Physicians Received $12 Billion from Drug, Device Makers in Less Than 10 YearsApril 3, 2024Business of Medicine
